Streetbeat News

COCH

Envoy Medical, Inc.

https://www.envoymedical.com

Industry

Medical - Devices

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

Open

1.98

Mkt cap

42M

Volume

78K

High

2.29

P/E Ratio

-2.58

52-wk high

11.46

Low

1.96

Div yield

N/A

52-wk low

0.75

Envoy Medical, a company focused on fully implanted hearing devices, has secured a $10 million lending facility, drawing $5 million initially. This funding, provided by major shareholder Glen Taylor, supports the company's growth and milestone achievements.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:07 pm

Envoy Medical shares are trading higher following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:24 pm

Envoy Medical (NASDAQ:COCH) reported Q2 EPS of $(0.27), missing the $(0.25) estimate, and sales of $68.00K, missing the $82.50K estimate. Despite the misses, EPS improved by 79.39% and sales increased by 7.94% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:45 pm

Envoy Medical has been added to the Russell Microcap Index, which could increase its visibility and attract more investors.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 12:05 pm

Envoy Medical shares are trading higher after Ascendiant Capital initiated coverage with a Buy rating and announced a price target of $8.50.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 2:25 pm

Ascendiant Capital has initiated coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and set a price target of $8.5.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 9:41 am

Envoy Medical has been included in the MSCI USA Micro Cap Index, which could increase its visibility and attract more investors.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 1:02 pm

Envoy Medical (NASDAQ:COCH) has highlighted a newly published peer-reviewed article in the Current Otorhinolaryngology Reports. The article reviews the current state of fully implanted cochlear implants, discussing challenges, limitations, and breakthroughs.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:06 pm

The article highlights the pre-market movements of 12 health care stocks on Tuesday. Notable gainers include Biodexa Pharmaceuticals (BDRX), Durect (DRRX), Larimar Therapeutics (LRMR), Tevogen Bio Holdings (TVGN), Envoy Medical (COCH), and Citius Pharma (CTXR). Significant losers include Scorpius Holdings (SCPX), Orgenesis (ORGS), SINTX Techs (SINT), Kazia Therapeutics (KZIA), NovaBay Pharmaceuticals (NBY), and Akanda (AKAN).

Portfolio Pulse from Benzinga Insights

May 21, 2024 | 12:06 pm

Envoy Medical (NASDAQ:COCH) reported a Q1 2024 GAAP EPS of $(0.32) and sales of $59.00K, missing the analyst consensus estimate of $100.00K by 41%.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:42 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.